Açiq mənbələrdən foto.

Açiq mənbələrdən foto.

Baku/20.08.21/Turan: The Russian Direct Investment Fund (RDIF) reported on successful trials of the joint use of “Sputnik V” and “AstraZeneca” vaccines.

It is noteworthy that the experiment is being carried out in Azerbaijan. According to a press release from RDIF, after vaccination of the "cocktail" of two vaccines, antibodies to the SARS-CoV-2 coronavirus were developed in 100% of the volunteers.

The joint research is being carried out by the R-Pharm group of companies, AstraZeneca and RDIF. 64 volunteers received a two-dose combination of both drugs. Analyzes of the first 20 participants in the study showed that antibodies to the S-protein of the SARS-CoV-2 coronavirus appeared in all observed patients.

Research in Azerbaijan began in February 2021 and is ongoing, the RDIF said.

Similar tests are being carried out in a number of countries, including Russia itself. -02D-

 

Leave a review

Social

Follow us on social networks

News Line